$LGND

$296.50▲ +0.5% YTD

6 SEC 13D/G filings tracked · Last updated Oct 15, 2026

Filing History

LGND ▲ +0.5% - Ligand Pharmaceuticals Incorporated

CP $296.50▲ +0.5%Oct 15, 2026 · ThinkSabio Blog

$LGND - Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026…

LGND ▼ -0.0% - Ligand Pharmaceuticals Incorporated

CP $298.41▲ -0.0%Sep 24, 2026 · ThinkSabio Blog

$LGND - Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million…

LGND ▼ -0.0% - Ligand Pharmaceuticals Incorporated

CP $290.00▲ -0.0%Sep 22, 2026 · ThinkSabio Blog

$LGND - Sydnexis Announces Royalty Agreement with Ligand for Ryjunea®…

LGND ▼ -0.0% - Ligand Pharmaceuticals Incorporated

CP $290.00▲ -0.0%Sep 22, 2026 · ThinkSabio Blog

$LGND - Primrose Bio® Raises Significant Growth Capital Investment Led by Signet Healthcare Partners…

LGND ▼ -0.0% - Ligand Pharmaceuticals Incorporated

CP $290.00▲ -0.0%Sep 22, 2026 · ThinkSabio Blog

$LGND Sydnexis Announces Royalty Agreement with Ligand for Ryjunea®…

LGND - Ligand Pharmaceuticals Incorporated - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified

$287.27▲ 51.38%Aug 13, 2026 · ThinkSabio Blog

$LGND SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #LGND Ligand Pharmaceuticals Incorporated : $287.27 Sector: Heal…